Knockdown of Rab27a has been shown to decrease the shedding of small EVs in fibrosarcoma (Sung et al., 2015), melanoma (Peinado et al., 2012), prostate (Webber et al., 2015), and breast cancer (Bobrie et al., 2012) cell lines. This evidence concerns the gene RAB27A and breast carcinoma.